What does CUSIP 64132R206 represent in this 13F holders report?

CUSIP 64132R206 is the security identifier for NRBO - NEUROBO PHARMACEUTICALS INC - COM NEW used to aggregate holder disclosures.

How many institutions held NRBO - NEUROBO PHARMACEUTICALS INC - COM NEW in Q1 2023?

8 institutional investors reported NRBO - NEUROBO PHARMACEUTICALS INC - COM NEW for Q1 2023. Use the holders table for investor-level position and value details.

NEUROBO PHARMACEUTICALS INC - COM NEW (NRBO)

CUSIP: 64132R206

Q1 2023 13F Holders as of 31 Mar 2023

Security type / class: Equity / COM NEW
Total 13F shares: 104,024
Total 13F value: $73,791
Share change: -1,289,373
SEC-reported price per share: $0.71
Number of holders: 8
Value change: -$924,388
Number of buys: 4
Number of sells: 11

Security key

64132R206

Report period

Q1 2023

Institutions

Top holders

NRBO full security history Ownership snapshot Full 13F holder table MetaVia Inc. SEC filings MetaVia Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of NRBO - NEUROBO PHARMACEUTICALS INC - COM NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

E&Investment, Inc.

Disclosed value leader

E&Investment, Inc.

Comparable rows

0/15

Latest evidence

31 Dec 2022

3/4/5 13F Highest disclosed value: $18,832,174 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

E&Investment, Inc. has the largest disclosed position value at $18.83M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens E&Investment, Inc.'s linked filing trail.

Disclosed position value Top 5

E&Investment, Inc. $18.83M

GOLDMAN SACHS GROUP INC $3.82M

SABBY MANAGEMENT, LLC $604K

CVI Holdings, LLC $154.3K

Walleye Capital LLC $68.2K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
E&Investment, Inc.	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$18,832,174 6,016,669 shares	—	26 Jul 2022
GOLDMAN SACHS GROUP INC	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$3,820,171 1,220,502 shares	—	16 Nov 2022
SABBY MANAGEMENT, LLC	13F Company 13F	— denominator unverified	$604,002 841,815 shares	—	31 Dec 2022
CVI Holdings, LLC	13F Company 13F	— denominator unverified	$154,295 215,045 shares	—	31 Dec 2022
Walleye Capital LLC	13F Company 13F	— denominator unverified	$68,163 95,000 shares	—	31 Dec 2022
TWO SIGMA INVESTMENTS, LP	13F Company 13F	— denominator unverified	$46,663 65,035 shares	—	31 Dec 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

104,024

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Holder diff

Investor	Q1 2023 Shares	Q1 2023 Shares	Share Diff	Share Chg %	Q1 2023 value	Q1 2023 value	Value change	Value Chg %